Ross, A., Donachie, P., Sallam, A., Stratton, I., Mohamed, Q., Scanlon, P., . . . Johnston, R. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
Chicago Style aipamenaRoss, A., P. Donachie, A. Sallam, I. Stratton, Q. Mohamed, P. Scanlon, J. Kirkpatrick, and R. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
MLA aipamenaRoss, A., et al. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.